Skip to main content

Bluestone Jeffrey's Form 4 filing

Gilead Sciences, Inc. (GILD) · filed Dec 1, 2025

Accession no.
0001771814-25-000005
Filed
Dec 1, 2025
Trade date
Nov 28, 2025
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $625.4K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bluestone JeffreyCIK 0001771814Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 28, 2025Common StockMOption exerciseAcquired+5,000$64.92+$324,60013,920Direct
Nov 28, 2025Common StockSSaleDisposed−5,000$125.08−$625,4008,920Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 28, 2025Common StockMOption exerciseDisposed−5,000$0.00$07,648Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)